Skip to main content
NCBI home page
Bacteriological Reviews logoLink to Bacteriological Reviews
. 1966 Jun;30(2):442–459. doi: 10.1128/br.30.2.442-459.1966

Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

M S Seelig
PMCID: PMC441005  PMID: 5327460

Full text

PDF
442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAMS G. D., BISHOP J. E. NORMAL FLORA AND LEUKOCYTE MOBILIZATION. Arch Pathol. 1965 Feb;79:213–217. [PubMed] [Google Scholar]
  2. ALLEN G. A., COOPER M. S. The effect of chlortetracycline on the immune response. Antibiot Annu. 1955;3:354–357. [PubMed] [Google Scholar]
  3. ALLISON F., Jr, ADCOCK M. H. THE INFLUENCE OF HYDROCORTISONE AND CERTAIN ELECTROLYTE SOLUTIONS UPON THE PHAGOCYTIC AND BACTERICIDAL CAPACITY OF LEUKOCYTES OBTAINED FROM PERITONEAL EXUDATE OF RATS. J Immunol. 1964 Mar;92:435–445. [PubMed] [Google Scholar]
  4. AMBROSE C. T., COONS A. H. Studies on antibody production. VIII. The inhibitory effect of chloramphenicol on the synthesis of antibody in tissue culture. J Exp Med. 1963 Jun 1;117:1075–1088. doi: 10.1084/jem.117.6.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ANDRIOLE V. T., KRAVETZ H. M., ROBERTS W. C., UTZ J. P. Candida endocarditis. Clinical and pathologic studies. Am J Med. 1962 Feb;32:251–285. doi: 10.1016/0002-9343(62)90294-2. [DOI] [PubMed] [Google Scholar]
  6. AUSTEN K. F., COHN Z. A. Contribution of serum and cellular factors in host defense reactions. I. Serum factors in host resistance. N Engl J Med. 1963 May 2;268:994–contd. doi: 10.1056/NEJM196305022681807. [DOI] [PubMed] [Google Scholar]
  7. BACHRACH E., GUILLOT N. Role inhibiteur du Lactobacillus acidophilus sur la croissance de Candida albicans (Rob.) Berkh. C R Hebd Seances Acad Sci. 1958 Feb 24;246(8):1277–1279. [PubMed] [Google Scholar]
  8. BARRETT B., JENSEN C. R., KIRBY W. M., VOLWILER W. Fatal systemic moniliasis following pancreatitis. AMA Arch Intern Med. 1957 Feb;99(2):209–213. doi: 10.1001/archinte.1957.00260020045007. [DOI] [PubMed] [Google Scholar]
  9. BECK W. S. The control of leukocyte glycolysis. J Biol Chem. 1958 May;232(1):251–270. [PubMed] [Google Scholar]
  10. BEEMER A. M., PRYCE D. M., RIDDELL R. W. Candida albicans infection of the gut. J Pathol Bacteriol. 1954 Oct;68(2):359–366. doi: 10.1002/path.1700680207. [DOI] [PubMed] [Google Scholar]
  11. BENDEL W. L., Jr, RACE G. J. Acute disseminated candidiasis in aplastic anemia. Potentiation by antibiotics and steroids. Arch Intern Med. 1961 Dec;108:916–924. doi: 10.1001/archinte.1961.03620120100013. [DOI] [PubMed] [Google Scholar]
  12. BOHNHOFF M., MILLER C. P. Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J Infect Dis. 1962 Sep-Oct;111:117–127. doi: 10.1093/infdis/111.2.117. [DOI] [PubMed] [Google Scholar]
  13. BRAUDE A. I., FELTES J., BROOKS M. Differences between the activities of mature granulocytes in leukemic and normal blood. J Clin Invest. 1954 Jul;33(7):1036–1046. doi: 10.1172/JCI102971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. BRAUDE A. I., ROCK J. A. The syndrome of acute disseminated moniliasis in adults. AMA Arch Intern Med. 1959 Jul;104(1):91–100. doi: 10.1001/archinte.1959.00270070093012. [DOI] [PubMed] [Google Scholar]
  15. BRODY J. I., FINCH S. C. Candida-reacting antibody in the serum of patients with lymphomas and related disorders. Blood. 1960 Jun;15:830–839. [PubMed] [Google Scholar]
  16. BYBEE J. D., ROGERS D. E. THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS. J Lab Clin Med. 1964 Jul;64:1–13. [PubMed] [Google Scholar]
  17. CAMPBELL P. J., HESELTINE W. W. An apparent growth stimulant for Candida albicans released from tetracycline-treated bacterial flora. J Hyg (Lond) 1960 Mar;58:95–97. doi: 10.1017/s0022172400038146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. COHN Z. A., AUSTEN K. F. Contribution of serum and cellular factors in host defense reactions. II. Cellular factors in host resistance. N Engl J Med. 1963 May 9;268:1056–concl. doi: 10.1056/NEJM196305092681906. [DOI] [PubMed] [Google Scholar]
  19. COHN Z. A. Determinants of infection in the peritoneal cavity. II. Factors influencing the fate of Staphylococcus aureus in the mouse. Yale J Biol Med. 1962 Aug;35:29–47. [PMC free article] [PubMed] [Google Scholar]
  20. COHN Z. A., MORSE S. I. Functional and metabolic properties of polymorphonuclear leucocytes. I. Observations on the requirements and consequences of particle ingestion. J Exp Med. 1960 May 1;111:667–687. doi: 10.1084/jem.111.5.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. COHN Z. A., MORSE S. I. Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med. 1959 Sep 1;110:419–443. doi: 10.1084/jem.110.3.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. CRUICKSHANK A. H. Resistance to infection in the alloxan-diabetic rabbit. J Pathol Bacteriol. 1954 Apr;67(2):323–334. doi: 10.1002/path.1700670205. [DOI] [PubMed] [Google Scholar]
  23. DE GAVALLER B. Moniliasis en los recién nacidos. Rev Obstet Ginecol Venez. 1953;13(2):203–217. [PubMed] [Google Scholar]
  24. DEBRE R., MOZZICONACCI P., DROUHET E., DROUHET V., HOPPELER A. Les infections à Candida chez le nourrisson. Ann Paediatr. 1955 Mar;184(3):129–164. [PubMed] [Google Scholar]
  25. DENNIS D. L., PETERSON C. G. CANDIDA ALBICANS SHOCK. Surg Forum. 1964;15:36–37. [PubMed] [Google Scholar]
  26. DENNIS D., MILLER M. J., PETERSON C. G. CANDIDA SEPTICEMIA. Surg Gynecol Obstet. 1964 Sep;119:520–530. [PubMed] [Google Scholar]
  27. DOBIAS B. Moniliasis in pediatrics. AMA J Dis Child. 1957 Sep;94(3):234–251. doi: 10.1001/archpedi.1957.04030040016004. [DOI] [PubMed] [Google Scholar]
  28. DONOMAE I., KAWAMORI Y. Moniliasis. J Antibiot (Tokyo) 1955 Dec;8(6):171–180. [PubMed] [Google Scholar]
  29. DROUHET E. Biologie des infections à Candida. II. Sur les manifestations pathologiques et les conditions étiologiques et pathogéniques de 175 cas de candidose. Sem Hop. 1957 Feb 28;33(13/2):807–828. [PubMed] [Google Scholar]
  30. DROUHET E. [Some mycological, pathogenetic and therapeutic aspects of candidiasis]. Bull Soc Fr Dermatol Syphiligr. 1960 Aug-Oct;67:646–659. [PubMed] [Google Scholar]
  31. ESMANN V. The glycogen content of leukocytes from diabetic and non-diabetic subjects. Scand J Clin Lab Invest. 1961;13:134–139. doi: 10.3109/00365516109137262. [DOI] [PubMed] [Google Scholar]
  32. FELISATI D., BASTIANINI L., DE MITRI T. Antibiotics and Candida albicans given by endobronchial route. Antibiot Chemother (Northfield) 1959 Dec;9:744–751. [PubMed] [Google Scholar]
  33. FOLEY G. E., WINTER W. D., Jr Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea. J Infect Dis. 1949 Nov-Dec;85(3):268–274. doi: 10.1093/infdis/85.3.268. [DOI] [PubMed] [Google Scholar]
  34. FOLEY M. J., WOOD W. B., Jr Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J Exp Med. 1959 Oct 1;110:617–628. doi: 10.1084/jem.110.4.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. GALE D., SANDOVAL B. Response of mice to the inoculations of both Candida albicans and Escherichia coli. I. The enhancement phenomenon. J Bacteriol. 1957 May;73(5):616–624. doi: 10.1128/jb.73.5.616-624.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. GEBHARDT L. P., HILL D. W. Morphological transformation of Candida albicans in tissues of mice. Proc Soc Exp Biol Med. 1956 Jul;92(3):640–644. doi: 10.3181/00379727-92-22570. [DOI] [PubMed] [Google Scholar]
  37. GERLOCZY F., SCHMIDT K., SCHOLZ M. Beiträge zur Frage der Moniliasis im Säuglingsalter. Ann Paediatr. 1956 Jul-Aug;187(1-2):119–133. [PubMed] [Google Scholar]
  38. GIUNCHI G. Candidosis following antibiotic therapy. Sci Med Ital. 1958 Apr-Jun;6(4):580–628. [PubMed] [Google Scholar]
  39. GORCZYCA L. R., McCARTY R. T. Effects of prolonged low dosage antibiotic administration and superimposed Candida albicans infection on goat serum proteins. Antibiot Chemother (Northfield) 1959 Oct;9:587–595. [PubMed] [Google Scholar]
  40. GRESHAM G. A., WHITTLE C. H. Studies of the invasive, mycelial form of Candida albicans. Sabouraudia. 1961 Jan;1:30–33. doi: 10.1080/00362176285190081. [DOI] [PubMed] [Google Scholar]
  41. GRUHN J. G., SANSON J. Mycotic infections in leukemic patients at autopsy. Cancer. 1963 Jan;16:61–73. doi: 10.1002/1097-0142(196301)16:1<61::aid-cncr2820160109>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  42. HALPERN B. THE RETICULO-ENDOTHELIAL SYSTEM AND IMMUNITY. Triangle. 1964 Apr;11:174–181. [PubMed] [Google Scholar]
  43. HASENCLEVER H. F., MITCHELL W. O. ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE. J Bacteriol. 1963 Sep;86:401–406. doi: 10.1128/jb.86.3.401-406.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. HENRY B., FAHLBERG W. J. The potentiating effect of hydrocortisone acetate and tetracycline on monilial infection in mice. Antibiot Chemother (Northfield) 1960 Feb;10:114–120. [PubMed] [Google Scholar]
  45. HIRSCH J. G., CHURCH A. B. Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro. J Exp Med. 1960 Mar 1;111:309–322. doi: 10.1084/jem.111.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. HUPPERT M., CAZIN J., Jr Pathogenesis of Candida albicans infection following antibiotic therapy. II. Further studies of the effect of antibiotics on the in vitro growth of Candida albicans. J Bacteriol. 1955 Oct;70(4):435–439. doi: 10.1128/jb.70.4.435-439.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. HUPPERT M., CAZIN J., Jr, SMITH H., Jr Pathogenesis of Candida albicans infection following antibiotic therapy. III. The effect of antibiotics on the incidence of Candida albicans in the intestinal tract of mice. J Bacteriol. 1955 Oct;70(4):440–447. doi: 10.1128/jb.70.4.440-447.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. HUPPERT M., MACPHERSON D. A., CAZIN J. Pathogenesis of Candida albicans infection following antibiotic therapy. I. The effect of antibiotics on the growth of Candida albicans. J Bacteriol. 1953 Feb;65(2):171–176. doi: 10.1128/jb.65.2.171-176.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. ISENBERG H. D., PISANO M. A., CARITO S. L., BERKMAN J. I. Factors leading to overt monilial disease. I. Preliminary studies of the ecological relationship between Candida albicans and intestinal bacteria. Antibiot Chemother. 1960 Jun;10:353–363. [PubMed] [Google Scholar]
  50. JOHNSON S. A. Candida (Monilia) albicans: effect of amino acids, glucose, pH, chlortetracycline (aureomycin), dibasic sodium and calcium phosphates, and anaerobic and aerobic conditions on its growth. AMA Arch Derm Syphilol. 1954 Jul;70(1):49–60. doi: 10.1001/archderm.1954.01540190051003. [DOI] [PubMed] [Google Scholar]
  51. KASHKIN P. N., KRASSILNICOV N. A., NEKACHALOV V. Y. Candida complications after antibiotic therapy. Mycopathol Mycol Appl. 1961 Jul 20;14:173–188. doi: 10.1007/BF02057324. [DOI] [PubMed] [Google Scholar]
  52. KEYE J. D., Jr, MAGEE W. E. Fungal diseases in a general hospital; a study of 88 patients. Am J Clin Pathol. 1956 Nov;26(11):1235–1253. doi: 10.1093/ajcp/26.11.1235. [DOI] [PubMed] [Google Scholar]
  53. KIMBALL S. G., BRODY J. I. Studies of in vivo phagocytosis. I. Inhibition of phagocytosis by intact neoplastic body fluids. Blood. 1963 Apr;21:462–469. [PubMed] [Google Scholar]
  54. KIM Y. P., ADACHI K., CHOW D. Leucine aminopeptidase in Candida albicans. J Invest Dermatol. 1962 Mar;38:115–116. doi: 10.1038/jid.1962.23. [DOI] [PubMed] [Google Scholar]
  55. KOSER S. A., HODGES E., TRIBBY I., STUEDELL J. T. Growth of lactobacilli in association with Candida albicans. J Infect Dis. 1960 Jan-Feb;106:60–68. doi: 10.1093/infdis/106.1.60. [DOI] [PubMed] [Google Scholar]
  56. KOZINN P. J., TASCHDJIAN C. L. Enteric candidiasis. Diagnosis and clinical considerations. Pediatrics. 1962 Jul;30:71–85. [PubMed] [Google Scholar]
  57. KOZINN P. J., TASCHDJIAN C. L., WIENER H., DRAGUTSKY D., MINSKY A. Neonatal candidiasis. Pediatr Clin North Am. 1958 Aug;5(3):803–815. doi: 10.1016/s0031-3955(16)30700-3. [DOI] [PubMed] [Google Scholar]
  58. KRASNER R. I., YOUNG G., YUDKOFSKY P. L. Interactions of oral strains of Candida albicans and lactobacilli. J Bacteriol. 1956 Oct;72(4):525–529. doi: 10.1128/jb.72.4.525-529.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  60. LI I. W., MUDD S., KAPRAL F. A. DISSOCIATION OF PHAGOCYTOSIS AND INTRACELLULAR KILLING OF STAPHYLOCOCCUS AUREUS BY HUMAN BLOOD LEUKOCYTES. J Immunol. 1963 May;90:804–809. [PubMed] [Google Scholar]
  61. LIPNIK M. J., KLIGMAN A. M., STRAUSS R. Antibiotics and fungous infections. J Invest Dermatol. 1952 Mar;18(3):247–260. doi: 10.1038/jid.1952.28. [DOI] [PubMed] [Google Scholar]
  62. LOURIA D. B., BRAYTON R. G. A SUBSTANCE IN BLOOD LETHAL FOR CANDIDA ALBICANS. Nature. 1964 Jan 18;201:309–309. doi: 10.1038/201309a0. [DOI] [PubMed] [Google Scholar]
  63. LOURIA D. B., BRAYTON R. G. BEHAVIOR OF CANDIDA CELLS WITHIN LEUKOCYTES. Proc Soc Exp Biol Med. 1964 Jan;115:93–98. doi: 10.3181/00379727-115-28840. [DOI] [PubMed] [Google Scholar]
  64. LOURIA D. B., FALLON N., BROWNE H. G. The influence of cortisone on experimental fungus infections in mice. J Clin Invest. 1960 Sep;39:1435–1449. doi: 10.1172/JCI104163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. LURIE M. B., ZAPPASODI P., DANNENBERG A. M., Jr, CARDONA-LYNCH E. The effect of cortisone and ACTH on the pathogenesis of tuberculosis. Ann N Y Acad Sci. 1953 Jul 17;56(4):779–792. doi: 10.1111/j.1749-6632.1953.tb27402.x. [DOI] [PubMed] [Google Scholar]
  66. LUTZ A., GROOTTEN O., WITZ M. A. Etude sur des champignons levuriformes du genre Candida; leur fréquence; l'action de la mycostatine et de la trichomycine. Rev Immunol Ther Antimicrob. 1957 Jul-Sep;21(4):237–259. [PubMed] [Google Scholar]
  67. MAIBACH H. I., KLIGMAN A. M. The biology of experimental human cutaneous moniliasis (Candida albicans). Arch Dermatol. 1962 Feb;85:233–257. doi: 10.1001/archderm.1962.01590020073009. [DOI] [PubMed] [Google Scholar]
  68. MANKOWSKI Z. T. The experimental pathogenicity of various species of Candida in Swiss mice. Trans N Y Acad Sci. 1957 Apr;19(6):548–570. doi: 10.1111/j.2164-0947.1957.tb00549.x. [DOI] [PubMed] [Google Scholar]
  69. MARSELOU U., SEGRETAIN G. Action des antibiotiques in vitro sur la croissance des Candida. Ann Inst Pasteur (Paris) 1954 Aug;87(2):229–233. [PubMed] [Google Scholar]
  70. MARTIN S. P., CHAUDHURI S. N., GREEN R., McKINNEY G. R. The effect of adrenal steroids on aerobic lactic acid formation in human leukocytes. J Clin Invest. 1954 Mar;33(3):358–360. doi: 10.1172/JCI102907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. MARTIN S. P., McKINNEY G. R., GREEN R., BECKER C. The influence of glucose, fructose, and insulin on the metabolism of leukocytes of healthy and diabetic subjects. J Clin Invest. 1953 Nov;32(11):1171–1174. doi: 10.1172/JCI102841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. MASSHOFF W., ADAM W. Histomorphologie der experimentellen Candida-Infektion. Arch Klin Exp Dermatol. 1957;204(5):416–447. [PubMed] [Google Scholar]
  73. MITCHELL G. W., SBARRA A. J. THE ROLE OF THE PHAGOCYTE IN HOST-PARASITE INTERACTIONS. II. THE PHAGOCYTIC CAPABILITIES OF LEUKOCYTES IN PREGNANT WOMEN. Am J Obstet Gynecol. 1965 Mar 15;91:755–762. doi: 10.1016/0002-9378(65)90450-3. [DOI] [PubMed] [Google Scholar]
  74. MIYA F., MARCUS S. Effect of humoral factors in vitro phagocytic and cytopeptic activities of normal and "immune" phagocytes. J Immunol. 1961 Jun;86:652–668. [PubMed] [Google Scholar]
  75. MOESCHLIN S., ZURUKZOGLU W., CRABBE J. Untersuchungen über den Einfluss von Cortison und ACTH auf die Phagozytose der Leukozyten und Makrophagen. Acta Haematol. 1953 May;9(5):277–288. doi: 10.1159/000204295. [DOI] [PubMed] [Google Scholar]
  76. MOORE M. In vivo and in vitro effect of aureomycin hydrochloride on Syringospora (Monilia, Candida) albicans. J Lab Clin Med. 1951 May;37(5):703–712. [PubMed] [Google Scholar]
  77. MOURAD S., FRIEDMAN L. Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med. 1961 Mar;106:570–572. doi: 10.3181/00379727-106-26405. [DOI] [PubMed] [Google Scholar]
  78. MOURAD S., FRIEDMAN L. Pathogenicity of Candida. J Bacteriol. 1961 Apr;81:550–556. doi: 10.1128/jb.81.4.550-556.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. MUDD S., YOSHIDA A., LI I. W., LENHART N. A. IDENTIFICATION OF A SOMATIC ANTIGEN OF STAPHYLOCOCCUS AUREUS CRITICAL FOR PHAGOCYTOSIS BY HUMAN BLOOD LEUCOCYTES. Nature. 1963 Sep 21;199:1200–1201. doi: 10.1038/1991200a0. [DOI] [PubMed] [Google Scholar]
  80. MUNOZ J., GEISTER R. Inhibition of phagocytosis by aureomycin. Proc Soc Exp Biol Med. 1950 Nov;75(2):367–370. doi: 10.3181/00379727-75-18201. [DOI] [PubMed] [Google Scholar]
  81. NICOL T., BILBEY D. L., CHARLES L. M., CORDINGLEY J. L., VERNON-ROBERTS B. OESTROGEN: THE NATURAL STIMULANT OF BODY DEFENCE. J Endocrinol. 1964 Oct;30:277–291. doi: 10.1677/joe.0.0300277. [DOI] [PubMed] [Google Scholar]
  82. NICOL T., SEWELL I. A. Effect of sulphonamides on the phagocytic activity of the reticulo-endothelial system. Nature. 1959 Oct 17;184(Suppl 16):1241–1242. doi: 10.1038/1841241b0. [DOI] [PubMed] [Google Scholar]
  83. O'GRADY F., COTTON R. E., THOMPSON R. E. MORPHOLOGY OF CORTISONE-INDUCED CHANGES IN MOUSE THIGH CANDIDIASIS. Br J Exp Pathol. 1964 Dec;45:656–665. [PMC free article] [PubMed] [Google Scholar]
  84. OLD L. J., CLARKE D. A., BENACERRAF B., GOLDSMITH M. The reticuloendothelial system and the neoplastic process. Ann N Y Acad Sci. 1960 Jun 21;88:264–280. doi: 10.1111/j.1749-6632.1960.tb20026.x. [DOI] [PubMed] [Google Scholar]
  85. OREN R., FARNHAM A. E., SAITO K., MILOFSKY E., KARNOVSKY M. L. Metabolic patterns in three types of phagocytizing cells. J Cell Biol. 1963 Jun;17:487–501. doi: 10.1083/jcb.17.3.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. PERILLIE P. E., FINCH S. C. The local exudative cellular response in leukemia. J Clin Invest. 1960 Sep;39:1353–1357. doi: 10.1172/JCI104153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. PERILLIE P. E., NOLAN J. P., FINCH S. C. Studies of the resistance to infection in diabetes mellitus: local exudative cellular response. J Lab Clin Med. 1962 Jun;59:1008–1015. [PubMed] [Google Scholar]
  88. PERKINS E. H., LEONARD M. R. Specificity of phagocytosis as it may relate to antibody formation. J Immunol. 1963 Feb;90:228–237. [PubMed] [Google Scholar]
  89. PINKERTON M. E., PATTERSON M. The effect of some selected antibiotics on experimental candidiasis. Tex Rep Biol Med. 1957;15(1):50–58. [PubMed] [Google Scholar]
  90. RANKIN J. G. Phagocytosis with special reference to hepatic function and disease. Med Clin North Am. 1963 May;47:737–752. doi: 10.1016/s0025-7125(16)33575-1. [DOI] [PubMed] [Google Scholar]
  91. ROGERS D. E. Host mechanisms which act to remove bacteria from the blood stream. Bacteriol Rev. 1960 Mar;24(1):50–66. doi: 10.1128/br.24.1.50-66.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. ROSEBURY T., GALE D., TAYLOR D. F. An approach to the study of interactive phenomena among microorganisms indigenous to man. J Bacteriol. 1954 Feb;67(2):135–152. doi: 10.1128/jb.67.2.135-152.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. ROTH F. J., Jr, BOYD C. C., SAGAMI S., BLANK H. An evaluation of the fungistatic activity of serum. J Invest Dermatol. 1959 May;32(5):549–556. doi: 10.1038/jid.1959.92. [DOI] [PubMed] [Google Scholar]
  94. ROTH F. J., Jr, GOLDSTEIN M. I. Inhibition of growth of pathogenic yeasts by human serum. J Invest Dermatol. 1961 May;36:383–387. doi: 10.1038/jid.1961.59. [DOI] [PubMed] [Google Scholar]
  95. ROTH F. J., Jr, MURPHY W. H., Jr Lethality of cell-free extract of Candida albicans for chlortetracycline-treated mice. Proc Soc Exp Biol Med. 1957 Mar;94(3):530–532. doi: 10.3181/00379727-94-23002. [DOI] [PubMed] [Google Scholar]
  96. SALVIN S. B. Endotoxin in pathogenic q fungi. J Immunol. 1952 Jul;69(1):89–99. [PubMed] [Google Scholar]
  97. SBARRA A. J., KARNOVSKY M. L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959 Jun;234(6):1355–1362. [PubMed] [Google Scholar]
  98. SCHAUBLE M. K., BAKER R. D. The inflammatory response in acute alloxan diabetes; enhanced proliferation of Rhizopus and Micrococcus in cutaneous lesions of rabbits. AMA Arch Pathol. 1957 Nov;64(5):563–569. [PubMed] [Google Scholar]
  99. SCHERR G. H. The effect of hormones on experimental moniliasis in mice. I. Sex hormones, cortisone, and somatotrophic hormone. Mycopathol Mycol Appl. 1957 Mar 25;8(1):62–72. doi: 10.1007/BF02053119. [DOI] [PubMed] [Google Scholar]
  100. SELIGMANN E. Virulence enhancement of Candida albicans by antibiotics and cortisone. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):778–781. doi: 10.3181/00379727-83-20488. [DOI] [PubMed] [Google Scholar]
  101. SELIGMANN E. Virulence enhancing activities of aureomycin on Candida albicans. Proc Soc Exp Biol Med. 1952 Mar;79(3):481–484. doi: 10.3181/00379727-79-19418. [DOI] [PubMed] [Google Scholar]
  102. SEWELL I. A., NICOL T. Effect of antibiotics on the phagocytic activity of the reticulo-endothelial system. Nature. 1958 Jun 14;181(4624):1662–1662. doi: 10.1038/1811662a0. [DOI] [PubMed] [Google Scholar]
  103. SHAYEGANI M. G., KAPRAL F. A., MUDD S. PHAGOCYTOSIS AND INTRACELLULAR KILLING OF STAPHYLOCOCCUS AUREUS BY HUMAN AND RABBIT BLOOD LEUKOCYTES. J Immunol. 1964 Jul;93:88–93. [PubMed] [Google Scholar]
  104. SHELDON W. H., BAUER H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med. 1959 Dec 1;110:845–852. doi: 10.1084/jem.110.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. SIMON H. J. EPIDEMIOLOGY AND PATHOGENESIS OF STAPHYLOCOCCAL INFECTION. I. AN EXPERIMENTALLY INDUCED ATTENUATED STAPHYLOCOCCAL INFECTION IN GUINEA PIGS AND ITS MODIFICATION BY TETRACYCLINE. J Exp Med. 1963 Aug 1;118:149–164. doi: 10.1084/jem.118.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. SMITH D. T. The disturbance of the normal bacterial ecology by the administration of antibiotics with the development of new clinical syndromes. Ann Intern Med. 1952 Dec;37(6):1135–1143. doi: 10.7326/0003-4819-37-6-1135. [DOI] [PubMed] [Google Scholar]
  107. SMITH H., FITZGEORGE R. B. THE EFFECT OF OPSONIZATION WITH ANTISERUM ON THE SURVIVAL OF BRUCELLA ABORTUS WITHIN BOVINE PHAGOCYTES. Br J Exp Pathol. 1964 Dec;45:672–674. [PMC free article] [PubMed] [Google Scholar]
  108. STEVENS K. M. The effect of antibiotics upon the immune response. J Immunol. 1953 Sep;71(3):119–124. [PubMed] [Google Scholar]
  109. STOLLERMAN G. H., KANTOR F. S., GORDON B. D. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med. 1958 Oct 1;108(4):475–491. doi: 10.1084/jem.108.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. STOLLERMAN G. H., RYTEL M., ORTIZ J. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms. J Exp Med. 1963 Jan 1;117:1–17. doi: 10.1084/jem.117.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. TASCHDJIAN C. L., KOZINN P. J. Laboratory and clinical studies on candidiasis in the newborn infant. J Pediatr. 1957 Apr;50(4):426–433. doi: 10.1016/s0022-3476(57)80252-2. [DOI] [PubMed] [Google Scholar]
  112. TORACK R. M. Fungus infections associated with antibiotic and steroid therapy. Am J Med. 1957 Jun;22(6):872–882. doi: 10.1016/0002-9343(57)90023-2. [DOI] [PubMed] [Google Scholar]
  113. VINCE S. The spread of Candida in infants and children. Med J Aust. 1959 Aug 1;46(2):143–145. doi: 10.5694/j.1326-5377.1959.tb100513.x. [DOI] [PubMed] [Google Scholar]
  114. WERTMAN K. F., HENNEY M. R. The effects of alloxan diabetes on phagocytosis and susceptibility to infection. J Immunol. 1962 Sep;89:314–317. [PubMed] [Google Scholar]
  115. WINNER H. I. A study of Candida albicans agglutinins in human sera. J Hyg (Lond) 1955 Dec;53(4):509–512. doi: 10.1017/s0022172400001005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. WINNER H. I. An experimental approach to the study of infections by yeast-like organisms. Proc R Soc Med. 1958 Jul;51(7):496–499. [PMC free article] [PubMed] [Google Scholar]
  117. WINNER H. I. Immunity in experimental moniliasis. J Pathol Bacteriol. 1956 Jan;71(1):234–237. doi: 10.1002/path.1700710132. [DOI] [PubMed] [Google Scholar]
  118. WINTER W. D., Jr, FOLEY G. E. Enhancement of Candida infection: differential distribution of renal lesions in mice treated with aureomycin. J Infect Dis. 1956 Mar-Apr;98(2):150–156. doi: 10.1093/infdis/98.2.150. [DOI] [PubMed] [Google Scholar]
  119. WU W. G., MARCUS S. HUMORAL FACTORS IN CELLULAR RESISTANCE. I. THE EFFECTS OF HEATED AND UNHEATED HOMOLOGOUS AND HETEROLOGOUS SERA ON PHAGOCYTOSIS AND CYTOPEPSIS BY NORMAL AND "IMMUNE" MACROPHAGES. J Immunol. 1963 Sep;91:313–322. [PubMed] [Google Scholar]
  120. ZALMAN M. V., FRASINEL N., NEAGOE N. PHAGOCYTOSE DES STAPHYLOCOQUES PATHOG'ENES SOUS L'ACTION DES ANTIBIOTIQUES. Arch Roum Pathol Exp Microbiol. 1963 Sep-Dec;22:919–930. [PubMed] [Google Scholar]
  121. ZIMMERMAN L. E. Fatal fungus infections complicating other diseases. Am J Clin Pathol. 1955 Jan;25(1):46–65. doi: 10.1093/ajcp/25.1.46. [DOI] [PubMed] [Google Scholar]

Articles from Bacteriological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES